Kexing Biopharm Logo

Kexing Biopharm

Develops and produces recombinant protein drugs and micro-ecological preparations.

688136 | Shanghai Stock Exchange

Overview

Corporate Details

ISIN(s):
CNE100006ZG6
LEI:
529900Z34Q1M9A907771
Country:
China
Address:
N/A

Description

Kexing Biopharm is an innovative biopharmaceutical enterprise engaged in the research, development, production, and sales of recombinant protein drugs and micro-ecological preparations. The company focuses on developing treatments for therapeutic areas including kidney diseases, oncology, antiviral therapy, autoimmune disorders, metabolic diseases, and degenerative diseases. A key product in its portfolio is Erythropoietin Injection. Kexing Biopharm maintains a comprehensive quality system that aligns with international standards, covering the entire drug lifecycle from production and quality control to release and transportation, ensuring the continuous and stable manufacturing of safe and effective medicines.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-01 21:05
Kexing Biopharm prasentiert globale Strategie und Kooperationsmoglichkeiten auf…
German 6.4 KB

Automate Your Workflow. Get a real-time feed of all Kexing Biopharm filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kexing Biopharm

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kexing Biopharm via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Binex Co., Ltd. Logo
Biopharmaceutical firm with pharma manufacturing and biologics CDMO services.
South Korea
053030
BioAge Labs, Inc. Logo
A clinical-stage biotech developing therapies for metabolic diseases by targeting aging.
United States of America
BIOA
BioAtla, Inc. Logo
Develops antibody-based therapeutics activated within the tumor microenvironment.
United States of America
BCAB
BIOBIJOU Co., Ltd. Logo
Develops and manufactures medical aesthetic products like H.A. fillers and skincare.
South Korea
489460
BioCardia, Inc. Logo
Develops cell-derived therapeutics for cardiovascular and pulmonary diseases.
United States of America
BCDA
Biocartis Group NV Logo
Develops and commercializes an automated molecular diagnostics platform for oncology.
Belgium
BCART
Bioceltix S.A. Logo
Develops stem cell-based medicinal products for veterinary use.
Poland
BCX
BIOCRYST PHARMACEUTICALS INC Logo
Develops novel medicines for patients with rare and serious diseases.
United States of America
BCRX
Biodexa Pharmaceuticals Plc Logo
Clinical-stage biopharma developing treatments for rare diseases, diabetes, and cancer.
United States of America
BDRX
Biofarm S.A. Logo
A pharmaceutical company that manufactures and markets medicines and dietary supplements.
Romania
BIO

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.